The Alfred Hauptmann Award is bestowed together with the German and Austrian epileptology associations to individuals or working groups for the best experimental or clinical research in the field of epileptology in German‐speaking countries.
It is awarded every two years and totals EUR 10,000.

Submissions should be works written in German or English that have been published or accepted for publication. They should be accompanied by the applicant’s curriculum vitae, a comment from the chair of the applicant’s home clinic/institution and, where there are several authors, an indication of the degree of involvement of each author. The e‐mail address for applications is:

The award is named after the German neurologist Alfred Hauptmann, who discovered the anticonvulsant efficacy of phenobarbital in 1912 and had to emigrate from Germany in 1933 because of his Jewish origins.

Further information is available in German at: